Diversifying its sources of genes for developing new genetically modified (GM) crop lines is not the only sign of Mahyco attempting to build a biotech research firm identity independent of Monsanto.

There is equal evidence of distance coming from Monsanto’s side as well.

The best indicator is GM maize: Unlike in Bollgard cotton – where the Indian licencee is a 50:50 joint venture between Mahyco and Monsanto – the American life sciences major has sought to introduce its ‘stacked’ three-gene transgenic corn hybrids through Monsanto India Ltd, in which Mahyco has no stake.

Monsanto’s GM corn, which is yet to receive regulatory clearances in India, has three genes. Two of them are Bt genes coding for proteins that acts against a broad spectrum of lepidopteran insect pests (similar to that for Bt cotton).

The third gene allows the maize hybrids to be tolerant to application of glyphosate herbicides that Monsanto now markets under the Roundup brand.

The fact that Monsanto has chosen to bring GM maize to India via its own subsidiary, rather than its existing joint venture with Mahyco, shows how both companies seem to be pursuing independent paths.

Related Topics